Spectroscopy E-Books
Historically, ion-exchange chromatography and size-exclusion chromatography (SEC) have been the reference techniques for the physicochemical characterization of biopharmaceutical compounds. However, reversed-phase liquid chromatography is naturally more compatible with mass spectrometry detection. This article discusses new trends in the use of ion-exchange chromatography and SEC, as well as the power of using ultrahigh-pressure liquid chromatography (UHPLC) and advanced reversed-phase LC columns, including sub-2-µm wide-pore porous particles or core–shell particles, for biopharmaceutical characterization. Read more
.
Innovative Drug Delivery System Enhances Rhein's Bioavailability and Therapeutic Potential
January 16th 2025Researchers from Northern Border University in Saudi Arabia have developed a rhein-loaded self-nano emulsifying drug delivery system (RS-SNEDDS), significantly enhancing the compound's solubility, bioavailability, and therapeutic potential, particularly for neurological applications.
Joseph P. Smith Named 2024 Emerging Leader in Molecular Spectroscopy by Spectroscopy Magazine
September 25th 2024Joseph P. Smith, Director of Process R&D Enabling Technologies at Merck has been awarded the 2024 Emerging Leader in Molecular Spectroscopy Award, recognizing his significant contributions to the advancement of molecular spectroscopy in the pharmaceutical industry.